ArticleJournal of the National Cancer Institute2013
Precision medicine for cancer patients: lessons learned and the path forward.
Article in Journal of the National Cancer Institute, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Asymmetric integration of various cancer datasets for identifying risk-associated variants and genes.Bioinformatics advances · 2025Article
- Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.CPT: pharmacometrics & systems pharmacology · 2017Article
- Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2017Article
- An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016Article
- Precision medicine: opportunities, possibilities, and challenges for patients and providers.Journal of the American Medical Informatics Association : JAMIA · 2016Article
- Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers.Molecular cancer research : MCR · 2015Article
- Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.Journal of the National Comprehensive Cancer Network : JNCCN · 2015Article
- Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.Journal of the National Cancer Institute · 2014Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.